Friday, November 13, 2026

Coffee Futures Is 10% Up In The Last 21 Sessions

Coffee Futures Is 10% Up In The Last 21 Sessions

(VIANEWS) - Coffee (KC) has been up by 10.6% for the last 21 sessions. At 05:52 EST on Tuesday, 18 June, Coffee (KC) is $227.50.

Volume

Today's last reported volume for Coffee is 2728, 87.29% below its average volume of 21477.72.

Volatility

Coffee's last week, last month's, and last quarter's current intraday variation average was 0.14%, 0.23%, and 2.95%, respectively.

Coffee's highest amplitude of average volatility was 2.18% (last week), 1.89% (last month), and 2.95% (last quarter), respectively.

News about

  • According to FXStreet on Monday, 17 June, "At the time of writing, Crude Oil (WTI) trades at $78.33and Brent Crude at $82.50"
  • Crude oil snaps higher as hopes of rising demand continue to bolster barrel bids. According to FXStreet on Monday, 17 June, "WTI US Crude Oil climbed back over the 200-day Exponential Moving Average (EMA) at $78.81, tipping into the touch range of the $80.00 handle as it continues an extended recovery from the recent multi-month swing low at $72.45.", "A planned phasing out of voluntary production cuts for OPEC ally member states, OPEC+, is expected to begin later in the year as OPEC+ begins to crack under the financial pressure of trying to prop up global Crude Oil prices. "
  • According to FXStreet on Tuesday, 18 June, "Apart from this, expectations that a drawdown in US inventories will tighten the market in the second half of the year should act as a tailwind for Crude Oil prices.", "Adding to this, the emergence of fresh buying around the US Dollar (USD), which continues to draw support from the Federal Reserve's (Fed) hawkish outlook, might also contribute to capping gains for Crude Oil prices. "

More news about Coffee (KC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com